Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model (Q44154809)

30 November 2017

title

Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model (English)

1 reference

30 November 2017

4

David Zurakowski

1 reference

30 November 2017

Frank Schuettauf

1

1 reference

30 November 2017

Kristine Quinto

series ordinal

2

1 reference

30 November 2017

Rita Naskar

series ordinal

3

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

42

1 reference

30 November 2017

issue

20

1 reference

30 November 2017

page(s)

2333-2337

1 reference

Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Preclinical safety profile of brimonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Ophthalmic drops causing coma in an infant.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Safety and efficacy of brimonidine in children with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Chronic ocular hypertension following episcleral venous occlusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

Genetic and environmental control of variation in retinal ganglion cell number in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2802%2900188-8

7 January 2021

10.1016/S0042-6989(02)00188-8

Identifiers

DOI

1 reference

30 November 2017

1 reference